Dustin Samples

Articles by Dustin Samples

Dustin SamplesConferences | October 17, 2023
It is important to monitor patients who have elevated CMV levels to detect infection and progression early.
Read More
Dustin SamplesConferences | October 17, 2023
Results from this meta-review suggest that more prophylactic strategies are needed in the fight against GVHD.
Dustin SamplesConferences | October 17, 2023
Intensive salvage therapy had a 54% complete remission rate whereas non-intensive salvage therapy was lower at 18%.
Dustin SamplesConferences | October 17, 2023
The study used only single-agent tacrolimus for GVHD prophylaxis.
Dustin SamplesConferences | October 17, 2023
Non-relapse mortality was low, and there was good GVHD control with the prophylaxis.
Dustin SamplesConferences | October 17, 2023
Results were further improved when Orca-T was given in combination with a regimen of busulfan, fludarabine, and thiotepa.
Dustin SamplesConferences | October 17, 2023
Rusfertide improved response maintenance and reduced the need for therapeutic phlebotomy.
Dustin SamplesGVHD | October 17, 2023
The trial cohort achieved a staggering 100% overall response rate after 7 days of treatment.
Dustin SamplesGVHD | October 17, 2023
The improvements occurred after haploidentical donor-matched transplant with PTCy and cord blood transplant.
Dustin SamplesConferences | October 17, 2023
Findings from this pilot study suggest that EVs may be a promising avenue for developing ocular GvHD therapies.
Dustin SamplesConferences | October 17, 2023
Differences in microRNA expression could help identify individuals at risk of developing GVHD.
Dustin SamplesConferences | October 17, 2023
Despite advances in understanding GVHD, outcomes remain poor for patients with T-PLL.
Dustin SamplesConferences | October 17, 2023
There was no increased risk of graft-versus-host disease with earlier administration.
Dustin SamplesConferences | October 17, 2023
The drug also did not appear to increase the risk of GVHD, though it did improve symptoms in 2 patients.
Dustin SamplesConferences | October 17, 2023
The study authors noted that PTCy-based prophylaxis provided reasonable GVHD control but did not affect OS or GRFS.
Dustin SamplesConferences | October 17, 2023
The incidence of grade III-IV GVHD was reduced in the cohort who received ATG as well.
Dustin SamplesConferences | October 17, 2023
Cytomegalovirus prophylaxis may improve outcomes after transplantation.
Dustin SamplesConferences | October 17, 2023
Though the degree of mismatch did not change GVHD incidence, mismatch was associated with GVHD.
Dustin SamplesConferences | October 17, 2023
In one case, early GVHD treatment with prednisolone, hemodialysis, ultrafiltration, and dobutamine improved heart health.
Dustin SamplesGI Cancer | September 1, 2023
Despite prior reports of an association between the conditions, a recent database review found no direct connection.